Thelansis

 Neonatal Seizures represent the most distinctive frequent manifestations of neurological dysfunction in the neonatal period. Neonatal seizures are clinically described as abnormal, stereotyped and paroxysmal dysfunctions in the central nervous system (CNS) occurring within the first 28 days after birth in full-term infants or before 44 weeks of gestational age in preterm infants. It is a relatively common occurrence in neonates with a heterogeneous etiology, and most infants are acutely symptomatic. The etiologies are different in term and preterm infants. Hypoxic-ischemic encephalopathy (HIE), stroke, cerebral malformations and metabolic disorders are major causes of seizures in term infants. Some significant causes in preterm infants are intraventricular haemorrhage (IVH), periventricular leukomalacia (PVL) and infections. Neonatal seizures are often the first clinical sign of underlying neurological dysfunction, with the most common causes being hypoxic-ischemic encephalopathy ...

  Neonatal seizures are a commonly encountered neurologic condition in newborns. They are defined as the occurrence of a sudden, paroxysmal, abnormal change in electrographic activity occurring at any time between birth and the end of the neonatal period. The neonatal brain is developmentally immature during this time. Thus, neonatal seizures have distinct pathophysiology and electrographic findings, resulting in clinical manifestations that differ (and are more difficult to distinguish) from those seen in older age groups. This activity examines the assessment and treatment of neonatal seizures and highlights the role of the interprofessional team in assessing and treating patients with this condition. Newborn babies have a central nervous system that is vulnerable to epileptogenic activity, and as a result, they have a relatively high incidence of seizures (12 per 1,000 term infants). Thelansis’s “Neonatal Seizures Market Outlook, Epidemiology, Competitive Landsca...